- Iran Nobel winner released for three weeks, 'unconditional' freedom urged
- Red Cross marks record numbers of humanitarians killed in 2024
- Johnson's Grand Slam 'no threat', says World Athletics boss Coe
- Qatar's emir and UK's Starmer talk trade as state visit ends
- Cuba suffers third nationwide blackout in two months
- Russia, Ukraine to send top diplomats to OSCE summit in Malta
- Spanish royals to attend memorial service for flood victims
- LPGA, USGA new policy requires female at birth or pre-puberty change
- Stick to current climate change laws, US tells top UN court
- British Museum chief says Marbles deal with Greece 'some distance' away
- Pope Francis receives electric popemobile from Mercedes
- Gaza civil defence: thousands flee Israeli strikes, evacuation calls
- Trump names billionaire private astronaut as next NASA chief
- Pidcock to leave INEOS Grenadiers at end of season
- Seoul stocks weaken, Paris advances despite political turmoil
- South America summit hopes to seal 'historic' trade deal with EU
- DAZN awarded global TV rights for Club World Cup
- Top executive shot dead outside New York hotel
- Vaping while still smoking unlikely to help quitters: study
- British Museum chief says Parthenon Marbles deal with Greece 'some distance' away
- 'Creating connections': Arab, African filmmakers gather at Morocco workshops
- Iran frees Nobel winner for three weeks, sparking calls for 'permanent' release
- Brazil's Minas cheese gets added to UNESCO list
- Top US executive shot dead in New York City: media
- Trump's nominee to run Pentagon hangs by a thread
- GM announces more than $5 bn hit to earnings in China venture
- World chess champ Ding, teen challenger tied past halfway mark
- Georgia police raid opposition offices as PM vows to curb protests
- S. Korea opposition begins push to impeach president
- Syrian army fights rebel offensive with counterattack
- France court upholds Polanski acquittal in defamation case
- UK bans daytime TV ads for cereals, muffins and burgers
- Palace's Guehi to face no formal action over 'Jesus' message on rainbow armband
- UK faces trade balancing act with Trump, EU
- Iran releases Nobel Peace laureate Mohammadi on medical leave: lawyer
- UNESCO grants heritage status to Aleppo soap as Syria war flares
- Ghana's illegal mining boom seeps into presidential election
- Inconsistent Spurs 'progressing in all aspects': Postecoglou
- France's Orano says Niger junta controls uranium firm
- Seoul stocks weaken, Paris edges up tracking political turmoil
- China reports warmest autumn since records began
- French marine park to close over law banning killer whale shows
- Thousands march demanding S. Korea president resign over martial law debacle
- Taiwan romance novelist Chiung Yao dies at 86
- In Angola, Biden promises to invest differently to China
- Syrian army launches counteroffensive against rebels
- Evenepoel says 'long journey' ahead after postal van collision
- South Korea's day of rage as Yoon's martial law founders
- UK police question killer nurse Letby over further baby deaths
- Cameroon curator Kouoh is first African woman to lead Venice Biennale
Japan firm probing 76 more deaths in supplement scare
Japanese health supplement maker Kobayashi Pharmaceutical said Friday it was probing 76 more deaths possibly linked to its tablets containing red yeast rice, meant to lower cholesterol.
It deepens a scandal that erupted earlier this year when the company said it was looking into five deaths potentially linked to the over-the-counter products after dozens of customers reported kidney problems.
Fermented with a mould culture, red yeast rice, or "beni koji", has been used in food, alcoholic drinks and folk medicines for centuries around East Asia.
"Even if the direct cause of hospitalisation or death was not kidney-related disease, it has become clear that there are a variety of cases, including cases in which beni koji-related products may have caused harm somehow and had some indirect impact," a Kobayashi statement said.
Of the five initial deaths under investigation, the company said it now knows one did not consume red yeast rice.
"We have received 1,656 inquiries from individuals who have sought medical attention, and have 76 cases under investigation over (a causal) connection to the deaths," in addition to the original four, it said.
On March 22, Kobayashi Pharmaceutical said it was recalling three kinds of tablets containing beni koji.
It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and government officials inspected the firm's facilities.
Kobayashi Pharmaceutical is a household name in Japan, offering a wide range of health-related products, and the scandal has been top news in the country.
On Friday, Kobayashi said it would work to identify the exact cause and scope of the health damage -- including whether organs other than kidneys were harmed.
Top government spokesman Yoshimasa Hayashi said Friday that the health ministry had previously ordered the company to file a daily report on its probe, and demanded more details earlier this month after the number of deaths under investigation didn't change.
"But until today, it had not reported the specific number of cases under investigation, and it is extremely regrettable," Hayashi told reporters.
Kobayashi Pharmaceutical has said it also sold red yeast rice to around 50 other firms in Japan and two in Taiwan.
Taiwanese companies preventively recalled 154 products containing red yeast rice in the wake of the scare, the island's health authorities said earlier this year.
I.Meyer--BTB